Specific inhibition of the nuclear exporter exportin-1 attenuates kidney cancer growth.
PURPOSE:Despite the advent of FDA-approved therapeutics to a limited number of available targets (kinases and mTOR), PFS of kidney cancer (RCC) has been extended only one to two years due to the development of drug resistance. Here, we evaluate a novel therapeutic for RCC which targets the exportin-...
Main Authors: | Hiromi I Wettersten, Yosef Landesman, Sharon Friedlander, Sharon Shacham, Michael Kauffman, Robert H Weiss |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4252068?pdf=render |
Similar Items
-
Human Exportin-1 is a Target for Combined Therapy of HIV and AIDS Related Lymphoma
by: Eline Boons, et al.
Published: (2015-09-01) -
In vitro toxicity and efficacy of verdinexor, an exportin 1 inhibitor, on opportunistic viruses affecting immunocompromised individuals.
by: Douglas G Widman, et al.
Published: (2018-01-01) -
Structural determinants of nuclear export signal orientation in binding to exportin CRM1
by: Ho Yee Joyce Fung, et al.
Published: (2015-09-01) -
Nuclear entry and export of FIH are mediated by HIF1α and exportin1 respectively
by: Wang, Y, et al.
Published: (2018) -
Inhibition of PPARα induces cell cycle arrest and apoptosis, and synergizes with glycolysis inhibition in kidney cancer cells.
by: Omran Abu Aboud, et al.
Published: (2013-01-01)